Amrutanjan Health Care submits 89th annual report, sets AGM for Sep 23

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Amrutanjan Health Care Limited filed its 89th Annual Report for FY26
  • The 89th AGM is scheduled for September 23, 2026, at 10:30 am
  • The meeting will be conducted via video conferencing or OAVM
  • Compliance follows SEBI LODR Regulations 34 and 36(1)(b)
powered bylight_fuzz_icon
49451511

*this image is generated using AI for illustrative purposes only.

Amrutanjan Health Care Limited has submitted its 89th Annual Report for the financial year ended March 31, 2026. The company scheduled its 89th Annual General Meeting for September 23, 2026, at 10:30 am via video conferencing or other audio-visual means.

The submission complies with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice is available on the company website. Shareholders without registered email addresses received a letter with a web link as per Regulation 36(1)(b).

Gagan Preet Singh, General Manager - Legal and Company Secretary & Compliance Officer, signed the disclosure on August 28, 2026.

How did Amrutanjan Health Care's financial performance in FY2026 compare to its previous year, particularly regarding revenue growth and net profit margins?

What strategic initiatives or new product launches does the company plan to prioritize in the upcoming fiscal year to maintain market competitiveness?

Did the company declare any dividends for FY2026, and how does this payout ratio align with shareholder expectations and industry standards?

like18
dislike

Amrutanjan Health Care commissions ₹150 cr Telangana sanitary napkin plant

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Amrutanjan Health Care Limited has commissioned its fifth manufacturing plant in Seetharampur Village, Telangana, with a ₹150 crore investment. The facility produces 700 million sanitary napkins annually using automated Japanese technology and creates 350 jobs.

powered bylight_fuzz_icon
47460344

*this image is generated using AI for illustrative purposes only.

Amrutanjan Health Care Limited has officially commissioned its new sanitary napkin manufacturing facility in Seetharampur Village, Shabad Mandal, Rangareddy District, Telangana. The greenfield project, located approximately 45 km from Hyderabad, represents a ₹150 crore investment aimed at scaling the company’s feminine hygiene operations under its Comfy brand. This development marks the company’s fifth manufacturing plant and is designed to leverage Hyderabad’s industrial ecosystem and connectivity to key markets across India.

The commissioning was disclosed to stock exchanges on August 5, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that the facility is now operational, transitioning from an investment phase to active production. This move strengthens Amrutanjan’s domestic manufacturing footprint and aligns with the "Make in India" initiative by establishing future-ready production capabilities in a strategic location.

Facility Specifications and Capacity

The new plant is spread across 10 acres with a built-up area of 1.4 lakh sq. ft. It features two fully automated high-speed production lines imported from Japan, positioning it among India’s fastest sanitary napkin manufacturing facilities. The design allows for capacity expansion based on market demand.

Parameter Details
Investment ₹150 crore
Location Seetharampur Village, Rangareddy District, Telangana
Area 10 acres (1.4 lakh sq. ft. built-up)
Annual Capacity 700 million sanitary napkins
Technology Two automated high-speed lines from Japan

Employment and Sustainability Impact

The facility is expected to generate significant local economic value by creating 200 direct and 150 indirect employment opportunities. This supports the regional workforce while strengthening the local manufacturing ecosystem in rural Telangana.

Sustainability features are integrated into the plant’s infrastructure, including rainwater harvesting, an on-site Sewage Treatment Plant (STP), waste recycling systems, and energy-efficient LED lighting. The company has also indicated plans to incorporate solar power in the future, reinforcing its commitment to responsible manufacturing practices.

Strategic Implications

With an annual production capacity of 700 million napkins, this facility significantly boosts Amrutanjan Health Care’s output capabilities. The strategic location near Hyderabad provides efficient access to raw materials and distribution networks, potentially reducing logistics costs and improving time-to-market for its Comfy brand products. As the company’s fifth plant, this expansion underscores a clear strategy to consolidate its leadership in the consumer healthcare sector through scaled, automated, and sustainable manufacturing.

How will the addition of 700 million units in annual capacity impact Amrutanjan's market share against established competitors like HUL and P&G in the Indian feminine hygiene sector?

What is the projected timeline for the integration of solar power at the new facility, and how will this affect the company's long-term operational cost structure and ESG ratings?

Will Amrutanjan leverage the strategic location near Hyderabad to expand its Comfy brand's distribution network into South India more aggressively, or will the output primarily serve national logistics hubs?

like19
dislike

More News on Amrutanjan Health Care